PATENT CLAIM ANALYSIS

Application Number: 15966844
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "254070"]

Abstract:
The present invention concerns methods for treating a proliferation disorder, such as prostate cancer, basal cell carcinoma, lung cancer, and other cancers, using an inhibitor of the Hedgehog pathway (HhP); and methods for monitoring subjects undergoing such treatments based on biomarkers and other criteria predictive of efficacy.

Claim (Index 13):
The method of  claim 11 , further comprising reducing a subsequent dose of an HhP inhibitor if the plasma trough level at about 4 weeks is at least 1000 ng/mL and the patient is experiencing one or more side effects.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 91.0
- Lexical Diversity: 1.27273
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15420283', '15966613', '15420247', '14173588', '11990729']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7947128335078323
- 35 USC 102 Novelty (BERT): 0.667170206007039
- Combined Prediction Score: 0.781958570757753
- Mean Citation Score: 570.0743160000002
- Max Citation Score: 657.5403
- Similarity Product: 652.2489265144942

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test